Tag Archives: telecare

Is de zorg klaar voor zelfmetingen?

English version >

Uit de Nictiz publicatie ‘zelfmetingen en de Nederlandse gezondheidszorg’ wordt duidelijk dat zelfmetingen nog niet of nauwelijks op de juiste manier in het reguliere zorgproces worden geïmplementeerd. Zelfmetingen starten op initiatief van de patiënt en behandelaar. Om zelfmetingen op een goede manier te kunnen regelen, worden er door Nictiz een aantal aanbevelingen gedaan.

  • De invoering van zelfmetingen in het reguliere zorgproces is nuttig en biedt veel kansen voor efficiëntere zorg; Vitaphone sluit zich hier helemaal bij aan. Wij zorgen voor de tools en services zodat personen op een eenvoudige en precieze wijze zelfmetingen kunnen doen en kunnen communiceren naar de arts.
  • Er is zeker behoefte aan standaarden zodat uitwisseling van gegevens mogelijk wordt. Daarbij moeten internationale standaarden voor interoperabiliteit en connectiviteit, zoals HL7, IHE en Continua Health Alliance, als uitgangspunt dienen.
  • Specifieke certificering van zelfmeetapparaten is nodig; hiermee wordt er vooral gedoeld op de verschillende apparaten (sensoren, mobiele apparaten en apps) die gegevens vastleggen, zodat de betrouwbaarheid van gegevens beter gegarandeerd is.
  • Naast de industrie en de consumenten zijn ook de zorgprofessionals aan zet; er is vaak weinig kennis over zelfmeetapparaten. Zorgprofessionals moeten zorgen voor kennis vergaring en overdracht.

De gezondheidszorg en -industrie is deels klaar voor verdere invoering van zelfmetingen, maar er moeten duidelijk nog verbeteringen doorgevoerd worden.

Auteur: Indy Kavelaars @ Vitaphone Netherlands

Bronnen: Whitepaper ‘Zelfmetingen en de Nederlandse gezondheidszorg’ door Nictiz

Tagged , , , ,

Connecting pharmacists with healthcare insurers, an improvement?

“There’s a missing connection in the health insurance exchange debate that could push mHealth to the forefront: pharmacists.” This is a valid point of Robert Oscar, president and CEO of RxEOB. Pharmacists help people with healthcare questions when they’re not in a doctor’s office. They are the ones that have data on medication adherence. Adherence to medication predicts how well treatment will work and if future (health)problems can be expected.

More and more pharmacists are looking for ways to achieve better services. These are services next to the medication adherence support. Monitoring blood pressure is a way to check effectiveness of the provided medication. The pharmacist can discuss the results with the physician and optimise the therapy (if needed). Better results stimulate patients to adhere, so it cuts both ways. Pharmacies and insurers should be connected to make rewards possible for pharmacies that achieve the best support on monitoring and adherence. Insurers and pharmacies become more aware that they need to cut into the nation’s healthcare bill and that they must provide tools to optimize patients treatments.

Do you think that pharmacies and healthcare insurers should work together more intensively? Please leave your comment below!

Author: Indy Kavelaars @ Vitaphone Netherlands

Source: mHealth News

Tagged , , , ,

Survey results: Remote monitoring of cardiac implantable electronic devices

The European society of cardiology recently published the results of their survey on remote monitoring of cardiac implantable electronic devices (CIEDs). The aim of the survey was to get insight into the current use of remote monitoring (RM) of CIEDs in Europe. Responses were received from 54 centres belonging to the European Heart Rhythm Association (EHRA) electrophysiological (EP) research network.

Some interesting results: a total of 76.5% of the centres reported that they are actively using remote monitoring. RM is most used for implantable cardioverter-defibrillators and rarely or never used for routine pacemaker checkups, because the latter seems to be less cost-effective.
In 29,8% of the European centres, the delay between detection of an abnormality by RM systems and the physician’s response is within 24h.
The face-to-face 6-month check-up visits are drastically reduced by RM. Only 17.6% of all centers perform internet check-ups at predefined intervals.

Some areas for improvement.
In only 6.4% of the cases information obtained by RM is incorporated into the clinical patient file! Why is that?
Also in 25% of the centres, there is no specific workflow designed for RM. Only with a clear workflow follow-up and registration of the findings is possible.
Almost 40% of the patients reported to prefer RM as their main follow-up management, because it helps to avoid unnecessary visits to the hospital.

We believe RM will become more and more accustomed! For the 23.5% of the centres that not use RM; let’s make it happen!

Author: Indy Kavelaars @ Vitaphone Netherlands

Source: Europace Oxfordjournals

Tagged , , , , , ,

True Value Telehealth

Eyeforpharma recently published a report called “True Value Telehealth” what gives a good insight in the current and future market of telehealth and telecare. I made a summary of the most valuable points of this report. Go to the link below for the full report.

Market now and for the future

Research firm InMedica predicts that the American telehealth market will grow by 600 percent between 2012 and 2017. This would represent an increase from the current 227,000 telehealth patients to reach up to 1.3m patients in 2017. They think this is mostly related to the reimbursement changes in the US.

In Europe, telehealth adoption is expected to gather pace as more governments seek innovative ways to manage budgetary pressures, amidst ongoing economic difficulties. According to a report by Deloitte, ‘Primary Care: Working differently: telecare and telehealth – a game changer for health and social care’ estimated spending on telehealth in Europe is 170 m€ in 2010. This figure is expected to increase to 353 m€ in 2015.

The diagram below shows the market share of telehealth and telecare in Europe. It is interesting to see that the UK has the biggest market share.

Market share telehealth europe

Market share telehealth europe

Developing markets

The developing countries are really emerging. This is because these countries are masters of maximizing resources. Take a diabetes management telehealth program as example: while the project uses relatively basic technology (SMS), it’s expected to have a huge impact on patients. Applications include reminders about diet, well-being, medicines, appointments and getting their prescriptions filled. The project has its limitations, but it will have an impact and it’s obviously really simple and low-cost to develop. So what we learn of this is that it doesn’t have to be complex and it doesn’t have to be expensive.

Why telemedicine works

Jon Linkous, CEO of the American Telemedicine Association, gives a clear message about the most important driver of telehealth. ‘Number one – telemedicine saves lives.’ Beyond this, Linkous notes, ‘it facilitates independent lifestyles, keeps people in their own homes in their own communities, it improves the quality of their care and it makes it a lot more convenient for the patient.’

Garth Sutherland, the CEO of Nexus6 a private company that provides electronic remote monitoring devices for inhaled drug delivery, also sees a major role for telehealth in helping to boost adherence. As an example, for newly diagnosed patients, he notes that, ‘it’s very important to establish great adherence to therapy very quickly.’ To enable this, ‘it requires a real-time system because it’s important that patient behaviors are driven towards adherence on a very timely basis. Following hospital admission, adherence drops from between 75-95% on the day after discharge to less than 50% after 10 days.’ I suggest to implement a medication adherence support system!

Costs, the biggest problem

One of the most common objections to adopt telehealth is cost. A World Health Organization survey found that the perception of costs for telehealth being too high is the greatest barrier for increased adoption of programs. However, cost concerns are most important in developing nations, where initial funding challenges must be overcome. In western countries, the debate centers on the cost-effectiveness of telehealth programs.


Rick Kates, who is the CEO of Viterion TeleHealthcare, also champions the importance of effective data integration. Key is, he says, to ensure that physicians are not ‘overwhelmed’ with the information.’ This can be achieved by understanding that they ‘don’t need more information, just better information.’ Kates also notes that interoperability of telehealth systems is essential. ‘Healthcare professionals and payers don’t want to be looking at multiple user interfaces and have to worry about whether or not certain data is going to come across and how it’s going to come across.’

Author: Indy Kavelaars @ Vitaphone Netherlands

Source: Eyeforpharma

Tagged , , , ,
%d bloggers like this: